Join
Live feed
·
INSIDERFilingvia Quantisnow
Monopar Therapeutics Inc. logo

Chief Executive Officer Robinson Chandler acquired 62,815 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MNPR· Monopar Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MNPR (Monopar Therapeutics Inc.) and more on Quantisnow.

Chief Executive Officer Robinson Chandler acquired 62,815 shares (SEC Form 4) | Quantisnow